Michael Rafii
Michael Rafii
Bestätigte E-Mail-Adresse bei usc.edu
Zitiert von
Zitiert von
Recent developments in Alzheimer's disease therapeutics
MS Rafii, PS Aisen
BMC medicine 7 (1), 1-4, 2009
A phase II trial of huperzine A in mild to moderate Alzheimer disease
MS Rafii, S Walsh, JT Little, K Behan, B Reynolds, C Ward, S Jin, ...
Neurology 76 (16), 1389-1394, 2011
Agrin and microvascular damage in Alzheimer’s disease
TM Berzin, BD Zipser, MS Rafii, V Kuo—Leblanc, GD Yancopouloš, ...
Neurobiology of aging 21 (2), 349-355, 2000
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease
MS Rafii, TL Baumann, RAE Bakay, JM Ostrove, J Siffert, AS Fleisher, ...
Alzheimer's & Dementia 10 (5), 571-581, 2014
High-throughput, fully-automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment
S Kovacevic, MS Rafii, JB Brewer
Alzheimer disease and associated disorders 23 (2), 139, 2009
Agrin in Alzheimer’s disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma
JE Donahue, TM Berzin, MS Rafii, DJ Glass, GD Yancopoulos, JR Fallon, ...
Proceedings of the National Academy of Sciences 96 (11), 6468-6472, 1999
Advances in Alzheimer’s disease drug development
MS Rafii, PS Aisen
BMC medicine 13 (1), 1-7, 2015
A phase 3 trial of IV immunoglobulin for Alzheimer disease
NR Relkin, RG Thomas, RA Rissman, JB Brewer, MS Rafii, CH Van Dyck, ...
Neurology 88 (18), 1768-1775, 2017
The National Task Group on Intellectual Disabilities and Dementia Practices consensus recommendations for the evaluation and management of dementia in adults with intellectual …
JA Moran, MS Rafii, SM Keller, BK Singh, MP Janicki
Mayo Clinic Proceedings 88 (8), 831-840, 2013
Evidence for a postnatal doubling of neuron number in the developing human cerebral cortex between 15 months and 6 years
WR Shankle, BH Landing, MS Rafii, A Schiano, JM Chen, J Hara
Journal of Theoretical Biology 191 (2), 115-140, 1998
Approximate doubling of numbers of neurons in postnatal human cerebral cortex and in 35 specific cytoarchitectural areas from birth to 72 months
WR Shankle, MS Rafii, BH Landing, JH Fallon
Pediatric and developmental pathology 2 (3), 244-259, 1999
Biglycan binds to α‐and γ‐sarcoglycan and regulates their expression during development
MS Rafii, H Hagiwara, ML Mercado, NS Seo, T Xu, T Dugan, RT Owens, ...
Journal of cellular physiology 209 (2), 439-447, 2006
Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS
ML Mercado, AR Amenta, H Hagiwara, MS Rafii, BE Lechner, RT Owens, ...
The FASEB journal 20 (10), 1724-1726, 2006
Adeno-associated viral vector (serotype 2)–nerve growth factor for patients with alzheimer disease: a randomized clinical trial
MS Rafii, MH Tuszynski, RG Thomas, D Barba, JB Brewer, RA Rissman, ...
JAMA neurology 75 (7), 834-841, 2018
Down's syndrome and Alzheimer's disease: towards secondary prevention
S Ness, M Rafii, P Aisen, M Krams, W Silverman, H Manji
Nature Reviews Drug Discovery 11 (9), 655-656, 2012
The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer’s disease biomarkers in down syndrome
M Rafii, H Wishnek, J Brewer, M Donohue, S Ness, W Mobley, P Aisen, ...
Frontiers in behavioral neuroscience 9, 239, 2015
PET imaging of tau pathology and relationship to amyloid, longitudinal MRI, and cognitive change in Down syndrome: results from the Down Syndrome Biomarker Initiative (DSBI)
MS Rafii, AS Lukic, RD Andrews, J Brewer, RA Rissman, SC Strother, ...
Journal of Alzheimer's Disease 60 (2), 439-450, 2017
Down syndrome
SE Antonarakis, BG Skotko, MS Rafii, A Strydom, SE Pape, DW Bianchi, ...
Nature Reviews Disease Primers 6 (1), 1-20, 2020
Outcome measures for clinical trials in Down syndrome
AJ Esbensen, SR Hooper, D Fidler, SL Hartley, J Edgin, XL d'Ardhuy, ...
American journal on intellectual and developmental disabilities 122 (3), 247-281, 2017
Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal‐dominant Alzheimer's disease
M Carmona‐Iragui, M Balasa, B Benejam, D Alcolea, S Fernández, ...
Alzheimer's & Dementia 13 (11), 1251-1260, 2017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20